Skip to main content
SpringerLink
Log in

Kardiomyopathien

  • Chapter
Herzkrankheiten

Zusammenfassung

Die Definition der Kardiomyopathien ist in den letzten 40 Jahren mehreren Änderungen unterworfen worden. Die aktuelle Definition und Klassifikation der Kardiomyopathien wurde 1995 von der WHO/ISFC-Task Force vorgelegt. Die Kardiomyopathien sind jetzt definiert als Myokarderkrankungen verbunden mit kardialer Dysfunktion. Sie werden bei unbekannter Ätiologie v.a. aufgrund ihrer Pathophysiologie, bei bekannter Ätiologie nach ätiologischen und pathogenetischen Gesichtspunkten klassifiziert. Die häufigste Form ist die dilatative Kardiomyopathie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abbasi AS, McAlpin RN, Eber LM et al (1972) Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 46:897

    Article  PubMed  CAS  Google Scholar 

  • Abelmann WH (1971) Virus and the heart. J Cardiovasc Med 9:695

    Google Scholar 

  • Adams KF Jr, Zannad F (1998) Clinical definition and epidemiology of advanced heart failure. Am Heart J 135:204

    Article  Google Scholar 

  • Alexander CS, Nino A (1969) Cardiovascular complications in young patients taking psychotherapeutic drugs. Amer Heart J 78:757

    Article  PubMed  CAS  Google Scholar 

  • Aretz H, Billingham M, Edwards W (1986) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14

    Google Scholar 

  • Aretz HT, Billingham ME, Edwards WD et al (1987) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol:3

    Google Scholar 

  • Badorff C, Lee G, Lamphear B (1999) Enteroviral protease 2A cleaves dystrophin: evidence cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326

    Article  PubMed  CAS  Google Scholar 

  • Bana DX, MacNeal PS, LeCompte PM et al (1974) Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. Am Heart J 88:640

    Article  PubMed  CAS  Google Scholar 

  • Berko B, Swift M (1987) X-linked dilated cardiomyopathy. N Engl J Med 316:1186–1191

    Article  PubMed  CAS  Google Scholar 

  • Bemheim PL (1910) De l’astolie veineuse dans l’hypertrophie du coer gauche, par sténose concomitante du ventricle droit. Rev Med 30:785

    Google Scholar 

  • Billmann GF (1990) Mechanisms responsible tor the cardiotoxic effects of cocaine. FASEB J 4:2469–2475

    Google Scholar 

  • Blair E, Redwood C, Ashrafian H (2001) Mutations in theä2 subunit of AMP activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10:1215–1220

    Article  PubMed  CAS  Google Scholar 

  • Blum RH, Carter SK (1974) Adriamycin: A new anti-cancer drug with significant clinical activity. Ann inter Med 80:249

    CAS  Google Scholar 

  • Braunwald E, Lambrew CT, Rockoff SD, Ross J, Morrow AG (1964) Idiopathic hypertrophie subaortic stenosis. A description of the disease based upon analysis of 64 patients. Circulation 30(Suppl IV):3

    PubMed  Google Scholar 

  • Braunwald E, Marrow AG, Cronell WF et al (1960) Idiopathic hypertrophie subaortic stenosis: Clinical, hemodynamic and angiographie manifestations. Amer J Med 29:924

    Article  Google Scholar 

  • Brem TH, Konwaller BE (1955) Fetal myocarditis due to emetine hydrochloride. Amer Heart J 50:477

    Article  Google Scholar 

  • Brock R (1957) Functional obstruction of the left ventricle. Guy’s Hospital Res 108:221

    Google Scholar 

  • Bryg RJ, Pearson AC, Williams GA, Labovitz AJ (1987) Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophie cardiomyopathy. Amer J Cardiol 59:925

    Article  PubMed  CAS  Google Scholar 

  • Burch GE, DePasquale NP, Cronvich JA (1965) Influence of ventricular size on the relationship between contractile and manifest tension. Amer Heart J 69:624

    Article  PubMed  CAS  Google Scholar 

  • Burch GE, Sohal RS, Sufi JC, Miller JC, Colcolough HL (1968) Effects of radiation on the human heart. An electron microscopic study. Arch intern Med 121:230

    Article  PubMed  CAS  Google Scholar 

  • Cannan C, Reeder G, Bailey K et al 1995) Natural history of hypertrophie cardiomyopathy: a population-based study, 1976 through 1990. Circulation 92:2488–2495

    Google Scholar 

  • Chandraratna PA, Nimalasuriya A, Reid CL et al (1983) Left ventricular asynergy in acute myocarditis. Stimulation of acute myocardial infarction. J Am Med Ass 250:1428

    Article  CAS  Google Scholar 

  • Cooke R, Chambers J, Curry P (1994) Noonan’s cardiomyopathy: a nonhypertrophic variant. Br Heart J 71:561–565

    Article  PubMed  CAS  Google Scholar 

  • Coonar A, Protonotarius N, Tsatsopoulou A et al (1998) Gene for arrythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantare keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 97:2049–2058

    Article  PubMed  CAS  Google Scholar 

  • Corrado G, Basso C, Thiene G (2000) Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis and treatment. Heart 83:588–595

    Article  PubMed  CAS  Google Scholar 

  • Cox G, Kunkel L (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329–343

    Article  PubMed  CAS  Google Scholar 

  • Dec GW, Fuster V (1994) Medical progress: Idiopathic dilated cardiomyopathy. N Engl J Med 331:1564

    Article  PubMed  CAS  Google Scholar 

  • Dempsy JJ, Salem HH (1966) An enzymatic electrocardiographic study on toxicity of dehydroemetine. Brit Heart J 28:505

    Article  Google Scholar 

  • Di Matteo J, Vacheron A, Heulin et al (1978) Complications cardiaques de la radiothérapie thoracique. Arch Mal Couer 71:447

    Google Scholar 

  • Dilsizian V, Bonow RO, Epstein SE, Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophie cardiomyopathy. J Am Coll Cardiol 22:796

    Article  PubMed  CAS  Google Scholar 

  • Doerr W (1971) Morphologie der Myokarditis. Verh dtsch Ges Inn Med 77:301

    PubMed  CAS  Google Scholar 

  • Duck H, Hutschenreiter W, Pankau H et al (1984) Vorhofsynchrone Ventrikelstimulation mit verkürzter A-V Verzögerungszeit als Therapieprinzip der hypertrophischen obstruktiven Kardiomyopathie. Z Gesamte Inn Med und ihre Grenzgebiete 39:437–447

    CAS  Google Scholar 

  • Elliott P, Sharma S, Varnava A et al (1999) Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophie cardiomyopathy. J Am Coll Cardiol 33:1596–1601

    Article  PubMed  CAS  Google Scholar 

  • Epstein S, Rosing DR (1981) Verapamil: Its potential for causing serious complications in patients with hypertrophie cardiomyopathy. Circulation 64:437–441

    Article  PubMed  CAS  Google Scholar 

  • Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophie obstructive cardiomyopathy: results with respect to intra proceduraI myocardial contrast echocardiography. Circulation 98:2415–2421

    Article  PubMed  CAS  Google Scholar 

  • Fananapazir L, Epstein N, Curiel R et al (1994) Long term results of DDD pacing in obstructive hypertrophie cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90:2731–2742

    Article  PubMed  CAS  Google Scholar 

  • Fernandez-Sola J, Estruch R, Grau J (1994) The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 120:529–536

    PubMed  CAS  Google Scholar 

  • Fernandez-Sola J, Estruch R, Nicolas J (1997) Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies. J Am Coll Cardiol 29:160–167

    Article  Google Scholar 

  • Fitzpatrick A, Shapiro L, Richards A et al (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63:114–118

    Article  PubMed  CAS  Google Scholar 

  • Fontaine G, Frank R, Vedel J et al (1977) Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus H (ed) Reentrant arrhythmias, pp 334–350. MTP Publishing, Lancaster

    Google Scholar 

  • Fowler NO (1971) Autoimmune heart disease. Circulation 44:159

    Article  PubMed  CAS  Google Scholar 

  • Frank S, Braunwald E (1968) Idiopathic hypertrophie subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37:759

    Article  PubMed  CAS  Google Scholar 

  • Franz W, Müller O, Katus H (2001) Cardiomyopathies: from genetics to the prospect of treatment. The Lancet 358:1627–1637

    Article  CAS  Google Scholar 

  • Frenzel H, Kasper M, Kuhn H et al (1985) Licht und elektronenmikroskopische Befunde in Früh-und Spätstadien der Herzinsuffizienz. Untersuchungen an Endomyokardbiopsien von Patienten mit latenter (LCM) und dilatativer (DCM) Kardiomyopathie. Z Kardiol 74:135

    PubMed  CAS  Google Scholar 

  • Fujioka S, Kitaura Y, Ukimura A (2000) Evaluation of viral infection in the myocardium of patients with dilated cardiomyopathy. J Am Coll Cardiol 36:1920–1926

    Article  PubMed  CAS  Google Scholar 

  • Furlan A, Craciun A, Raju N et al (1984) Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke 15:282–284

    Article  PubMed  CAS  Google Scholar 

  • Ghosh P et al (1972) Myocardial sarcoidosis. Brit Heart J 34:769

    Article  PubMed  CAS  Google Scholar 

  • Gilbert EM, SDi Lenarda A, O’Connell JB (1993) Prognosis and management, dilated cardiomyopathy. In: Goodwin J, Olsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 46–63

    Chapter  Google Scholar 

  • Giardina EGV, Johnson LL, Vita J et al (1985) Effect of imipramine and nortriptyline on left ventricular function and blood press ure in patients treated for arryhthmias. Am Hear J 109:992

    Article  CAS  Google Scholar 

  • Gietzen F, Leuner C, Obergassel L et al (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophie cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106:454–459

    Article  PubMed  Google Scholar 

  • Gilligan D, Chan W, Joshi J (1993) A double blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophie cardiomyopathy. J Am Coll Cardiol 21:1672–1679

    Article  PubMed  CAS  Google Scholar 

  • Goodwin JF (1970) Congestive and hypertrophie cardiomyopathies. Lancet 1:731

    Article  Google Scholar 

  • Goodwin JF (1993) Clinical aspects. In. Goodwin J, Alsen E (eds) Cardiomyopathy. Springer, Berlin Heidelberg New York

    Chapter  Google Scholar 

  • Gore I, Saphir O (1967) Myocarditis a classification of 1402 cases. Amer Heart J 34:827

    Article  Google Scholar 

  • Grunig et al (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Card 31:186–194

    Article  CAS  Google Scholar 

  • Guillo P, Manuorati J, Maheu B et al (1997) Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 79:1276–1278

    Article  PubMed  CAS  Google Scholar 

  • Hagemann GJ, Wurm K (1978) Electrocardiographic findings in sarcoidosis. 7. Congress in sarcoidosis. Card

    Google Scholar 

  • Halazoun JF, Wagner HR, Geata JF (1974) Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. Cancer 33:545

    Article  Google Scholar 

  • Hassenstein P, Wolter H (1967) Therapeutic management of a critical situation in a patient with idiopathic hypertrophie subaortic stenosis. Verh Dtsch Ges Kreislaufforsch 33:242–246

    PubMed  CAS  Google Scholar 

  • Heydemann A, Wheeler M, McNally M (2001) Cardiomyopathy in animal models of muscular dystrophy. Curr Opinion Cardiol 16:211–217

    Article  CAS  Google Scholar 

  • Hudson RE (1970) The cardiomyopathies: Order from chaos. Amer J Cardiol 25:70

    Article  PubMed  CAS  Google Scholar 

  • Hutchins GM, Bulkley BH (1978) Catenoid shape of the interventricular septum: Possible cause of idiopathic hypertrophie subaortic stenosis. Circulation 58:392

    Article  PubMed  CAS  Google Scholar 

  • Ichida F et al (2001) Novel gene mutations in patients with left ventricular non-compaction or Barth Syndrome. Circulation 103:1256–1263

    Article  PubMed  CAS  Google Scholar 

  • Ishanov A, Okamoto H, Yoneya K (1997) Angiotensinogen gene polyphormism in Japanese patients with hypertrophie cardiomyopathy. Am Heart J 133:184–189

    Article  PubMed  CAS  Google Scholar 

  • Jarcho J et al (1989) Mapping a gene for familial hypertrophie cardiomyopathy to chromosome 14q1. N Engl J Med 321:1372–1378

    Article  PubMed  CAS  Google Scholar 

  • Klein LS, Simpson RJ Jr, Stern R et al (1982) Myocardial infarction following administration of sub lingual ergotamine. Chest 82:375

    Article  PubMed  CAS  Google Scholar 

  • Kloner RA, Hale S, Alker K, Rezkalla S (1992) The effects of acute and chronic cocaine use on the heart. Circulation 85:407

    Article  PubMed  CAS  Google Scholar 

  • Kostis JB, Moreyra AE, Natarajan N et al (1979) The pathophysiology and diverse etiology of septal perforator compression. Circulation 59:913

    Article  PubMed  CAS  Google Scholar 

  • Kuhn H, Becker R, Fischer J et al (1982) Untersuchungen zur Ätiologie, zum Verlauf und zur Prognose der dilatativen Kardiomyopathie (DCM). Z Kardiol 71:497

    PubMed  CAS  Google Scholar 

  • Kühl U, Pauschinger M, Schwimmbeck PL et al (2003) Interferon-ß treat-ment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793–2798

    Article  PubMed  CAS  Google Scholar 

  • Kushwaha S, Fallon J, Fuster V (1997) Restrictive cardiomyopathie. N Engl J Med 336:267–276

    Article  PubMed  CAS  Google Scholar 

  • Lauer B, Padberg K, Schultheiss HP, Strauer BE (1995) Autoantikörper gegen kardiales Myosin bei Patienten mit Myokarditis und dilatativer Kardiomyopathie. Z Kardiol 84:301

    PubMed  CAS  Google Scholar 

  • Levine DG, Marshall AJ (1975) Cardiac arrhythmias induced by phenothiazine. Lancet 11:990

    Google Scholar 

  • Lewis BS, Gotsman MS (1973) Selective coronary angiography in primary myocardial disease. Brit Heart J 35:165

    Article  PubMed  CAS  Google Scholar 

  • Linzbach AJ (1960) Die pathologische Anatomie der Herzinsuffizienz. In: Schwiegk H (Hrsg) Handbuch der inneren Medizin, Bd 9/1, S 706. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Linzbach AJ, Kyrieleis C (1968) Strukturelle Analyse chronisch insuffizienter menschlicher Herzen. In: Reindell H, Keul J, Doll E (Hrsg) Herzinsuffizienz. Internationales Symposium, 2.5.11.1957, Hinterzarten, S 11. Thieme, Stuttga

    Google Scholar 

  • Maaron B (1997) Hypertrophie cardiomyopathy. Lancet 350:127–133

    Article  Google Scholar 

  • Maaron B, Bonow R, Cannon R et al (1987) Hypertrophie cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 316:780–789

    Article  Google Scholar 

  • Maaron B, Gross B, Stark S (1995) Extreme left ventricular hypertrophy. Circulation 92:2748

    Article  Google Scholar 

  • Maaron B, Nishimura R, McKenna W et al (1999) M-Pathy-Study. Circulation 99:2927–2933

    Article  Google Scholar 

  • Maaron B, Olivotto I, Spirito P et al (2000a) Epidemiology of hypertrophie cardiomyopathy-related death: revisited in a large non-referralbased patient population. Circulation 102:858–864

    Article  Google Scholar 

  • Maaron B, Shen W, Link M (2000b) Efficacy of implantable cardioverterdefibrillators for the prevention of sudden death in patients with hypertrophie cardiomyopathy. N Engl J Med 342:365–373

    Article  Google Scholar 

  • Maaron M, Olivotto I, Batocchi S et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophie cardiomyopathy. N Engl J Med 348:295–303

    Article  Google Scholar 

  • Maisch B (1998) Einteilung der Kardiomyopathien nach der WHO/ ISFC Task force — Mehr Fragen als Antworten? Med Klinik 93:199–209

    Article  CAS  Google Scholar 

  • Maisch B, Funcker R, Alter P et al (2002). Dilatative Kardiomyopathie und Myokarditis, Internist 43 (Suppl I) 45–65

    Article  Google Scholar 

  • Marian A (2000) Pathogenesis of diverse clinical and pathological phenotypes in hypertrophie cardiomyopathy. Lancet 355:58–60

    Article  PubMed  CAS  Google Scholar 

  • Marian A, Yu Q, Workman R et al (1993) Angiotensin converting enzyme polymorphism in hypertrophie cardiomyopathy and sudden cardiac death. Lancet 342:1085–1086

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Clark CE, Henry WL et al (1977) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with aquired or congenital heart disease. Circulation 55:489

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle tell disorganization in the ventricular septum of patients with hypertrophie cardiomyopathy. Circulation 59:689

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophie cardiomyopathy: A profile of 78 patients. Circulation 65:1388

    Article  PubMed  CAS  Google Scholar 

  • Martin RP, Rakowski H, French J, Popp RL (1979) Idiopathic hypertrophie subaortic stenosis viewed by wide-angle, phased-array echocardiography. Circulation 59:1206

    Article  PubMed  CAS  Google Scholar 

  • Mason SW, O’Connel J, Herskowitz A et al (1995) A clinical trial of immunsuppressive therapy for myocarditis. N Engl J Med 333:269–275

    Article  PubMed  CAS  Google Scholar 

  • Massie BM, Schiller NB, Ratshin RR, Parmley WW (1977) Mitral septal separation: New echocardiographic index of left ventricular function. Amer J Cardiol 39:1008

    Article  PubMed  CAS  Google Scholar 

  • Matsui Y, Kazvoiswai T, Thukibana T, Frive T (1976) Clinicopathological study of total myocardial sarcoidosis. Ann NY Acad Sci 278:455

    Article  PubMed  CAS  Google Scholar 

  • Mattingly TW (1970) Diseases of the myocardium (cardiomyopathies): The viewpoint of a clinical cardiologist. Amer J Cardiol 25:79

    Article  PubMed  CAS  Google Scholar 

  • May G (1975) Virusätiologie der Myokarditis. Diagnostik 8:182

    Google Scholar 

  • McDonald IG, Feigenbaum H, Chang S (1972) Analysis of left ventricular wall motion by reflected ultrasound. Application to assessment of myocardial function. Circulation 46:14

    Article  PubMed  CAS  Google Scholar 

  • Mazur W, Nagueh S, Lakkis N et al (2001) Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 103:1492–1496

    Article  PubMed  CAS  Google Scholar 

  • McCully R, Nishimura R, Tajik A et al (1996) Extent of clinical improvement after surgical treatment of hypertrophie obstructive cardiomyopathy. Circulation 94:467–471

    Article  PubMed  CAS  Google Scholar 

  • McKoy G, Protonotarios N, Crosby A et al (2000) Identification of a deletion in plakoglobin in arrythmogenic right ventricular cardiomyopathy with palmoplantar keratosis and woolly hair (Naxos disease). Lancet 355:2119–2124

    Article  PubMed  CAS  Google Scholar 

  • Meessen H (1974) Über Herzhypertrophie. Lebensversicherungsmedizin 26:102

    PubMed  CAS  Google Scholar 

  • Meinertz T, Hohnloser S, Zehender M et al (1987) Plötzlicher Herztod — wie erkennt man gefährdete Patienten? Z Kardiol 76, Suppl 2

    Google Scholar 

  • Messer JV, Neill WA (1962) The oxygen supply of human heart. Amer J Cardiol 9:384

    Article  PubMed  CAS  Google Scholar 

  • Mintz HS, Kotler MN, Segal BL, Party WR (1978) Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy. Circulation 57:256

    Article  PubMed  CAS  Google Scholar 

  • Mirsky I, Cohn PF, Levine JA et al (1974) Assessment of left ventricular stiffness in primary myocardial disease and coronary artery disease. Circulation 50:128

    Article  PubMed  CAS  Google Scholar 

  • Mogensen J, Klausen I, Pedersen A (1999) A cardiac actin is a novel disease gene in familial dilated cardiomyopathy. J Clin Invest 103:39–43

    Article  Google Scholar 

  • Morrow AG (1978) Hypertrophie subaortic stenosis: Operative methods utilized to relieve left ventricular outflow obstruction. J thorac cardiovasc Surg 76:423–430

    PubMed  CAS  Google Scholar 

  • Motté G, Waynberger M, Bailly J et ai (1970) Myocarditis émétienne. A propos d’un cas morte du a la 2-dehydroémétine. Ann Med Int (Paris) 12:979

    Google Scholar 

  • Nicod P, Polikar R, Peterson K (1988) Hypertrophie cardiomyopathy and sudden death. N Engl J Med 318:1255–1257

    Article  PubMed  CAS  Google Scholar 

  • Nieminen MS, Heikkilä J, Karjalainen J (1984) Echocardiography in acute infectious myocarditis: Relation to clinical and electrocardiographic findings. Am J Cardiol 53:1331

    Article  PubMed  CAS  Google Scholar 

  • Olson T, Michels V, Thibodeau S et al (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280:750–752

    Article  PubMed  CAS  Google Scholar 

  • Patel R, Lim D, Reddy D (2000) Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophie cardiomyopathy. J Mol Cell Cardiol 32:2369–2377

    Article  PubMed  CAS  Google Scholar 

  • Pisani B, Taylor D, Mason S (1997) Inflammatory myokardial disease and cardiomyopathies. Am S med 102:459

    Article  CAS  Google Scholar 

  • Poche R (1982) Pathologie der Kardiomyopathien und Myokardiopathien. In: Roskamm H, Reindell H (Hrsg) Herzkrankheiten, 2. Aufl, S 1055. Springer, Berlin Heidelberg New York

    Chapter  Google Scholar 

  • Pollick C (1982) Muscular subaortic Stenosis: hemodynamic and clinical improvement after disopyramide. N Engl J Med 72:1001–1007

    Google Scholar 

  • Prentice R (1965) Myocardial infarction following radiation. Lancet 11:388

    Article  Google Scholar 

  • Prystowsky E, Benson D, Fuster V et al (1996) Management of patients with atrial fibrillation: a statement for healthcare professionals: from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93:1262–1277

    Article  PubMed  CAS  Google Scholar 

  • Raisfeld IH (1972) Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Amer Heart J 83:129

    Article  PubMed  CAS  Google Scholar 

  • Reindell H, Görnandt L, Bubenheimer P, Dickhuth HH (1988) Kardiomyopathien. In: Reindell H, Budenheimer P, Dickhuth HH, Görnandt L (Hrsg) Funktionsdiagnostik des gesunden und kranken Herzens, S 230. Thieme, Stuttgart

    Google Scholar 

  • Robbins R, Stinson E (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophie cardiomyopathy. J Thorac Cardiovasc Surg 111:586–594

    Article  PubMed  CAS  Google Scholar 

  • Robinson K, Frenneaux M, Stockins B et al (1990) Atrial fibrillation in hypertrophie cardiomyopathy: a longitudinal study. J Am Coll Cardiol 15:1279–1285

    Article  PubMed  CAS  Google Scholar 

  • Rosenbaum MN (1964) Chagasic myocardiopathy. Progr cardiovasc Dis 7:199

    Article  CAS  Google Scholar 

  • Roskamm H, Blümchen G, Fiebig H et al (1972) Hämodynamik und Kontraktilitätsreserve bei Myokardiopathien. Dtsch med Wschr 44:1681

    Article  Google Scholar 

  • Rossen RM, Goodman DJ, Ingham RE, Popp RL (1974) Echocardiographic criteria in the diagnosis of idiopathic hypertrophie subaortic stenosis. Circulation 50:747

    Article  PubMed  CAS  Google Scholar 

  • Saphir O (1959) Myokarditis. Amer Heart J 57:639

    Article  PubMed  CAS  Google Scholar 

  • Savage DD, Seides SF, Maron BJ et al (1979) Prevalence of arrhythmias during 24-hours electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophie cardiomyopathy. Circulation 59:866

    Article  PubMed  CAS  Google Scholar 

  • Saumarez R, Slade A, Grace A et al (1995) The significance of paced electrocardiogram fractionation in hypertrophie cardiomyopathy. Circulation 91:2762–2768

    Article  PubMed  CAS  Google Scholar 

  • Savage DD, Drayer JIM, Henry WL et al (1970) Echocardiographic assessment of cardiac function in hypertensive subjects. Circulation 59:623

    Article  Google Scholar 

  • Schell FC, Yap H-Y, Blumenschein G et al (1982) Potential cardiotoxicity wirb mitoxantrone. Cancer Treat Rep 66:1641

    PubMed  CAS  Google Scholar 

  • Scheuer J (1970) Metabolism of the heart in heart failure: Progr cardiovasc Dis 13:24

    Article  CAS  Google Scholar 

  • Schölmerich P (1971) Klinik der Myokarditis. Verh dtsch Ges inn Med 77:335

    PubMed  Google Scholar 

  • Schultheiss HP, Strauer BE (1992) Behandlung der entzündlichen Herzkrankheit. Arzneimitteltherapie 10:170

    Google Scholar 

  • Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophie obstructive cardiomyopathy. Eur Heart J 21:704–707

    Article  PubMed  CAS  Google Scholar 

  • Shah PM, Gramiak R, Adelman AG, Wigle ED (1971) Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophie subaortic stenosis. Circulation 44:891

    Article  PubMed  CAS  Google Scholar 

  • Shamim W, Yousufuddin M, Wang D et al (2002) Nonsurgical reduction of the interventricular septum in patients with hypertrophie cardiomyopathy. N Engl J Med 347:1326–1333

    Article  PubMed  Google Scholar 

  • Sigwart U (1995) Non-surgical reduction for hypertrophie obstructive cardiomyopathy. Lancet 346:211–214

    Article  PubMed  CAS  Google Scholar 

  • Slade A, Sadoul N, Shapiro L et al (1996) DDD pacing in hypertrophie cardiomyopathy: a multicentre clinical experience. Heart 75:44–49

    Article  PubMed  CAS  Google Scholar 

  • Spiller P, Brenner K, Kreuzer H et al (1975) Systolische Ventrikel-und Myokardfunktion bei hypertrophischer obstruktiver Kardiomyopathie. Z Kardiol Suppl 2:8

    Google Scholar 

  • Spirito P, Bellone P, Harris K et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophie cardiomyopathy. N Engl J Med 342:1778–1785

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Maaron B (1999) Perspectives on the role of new treatment strategies in hypertrophie cardiomyopathy. J Am Coll Cardiol 33:1071–1075

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Maaron B, Bonow R et al (1987) Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophie cardiomyopathy. Am J Cardiol 60:123–129

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Rapezzi C, Autore C et al (1994) Prognosis of asymptomatic patients with hypertrophie cardiomyopathy and nonsustained ventricular tachycardia. Circulation 90:2743–2747

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Seidman C, McKenna W, Maron B (1997) The management of hypertrophie cardiomyopathy. N Engl J Med 336:775–785

    Article  PubMed  CAS  Google Scholar 

  • St John Sutton MG, Tajik AJ, Gibson DG et al (1978) Echocardiographic assessment of left ventricular filling and septal andposterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation 57:512

    Article  Google Scholar 

  • Stetson S et al (2000) Evidence for reversible dystrophin abnormalities in patients with non-familial dilated cardiomyopathies: observations in patients treated with long-term mechanical support. Circulation 102:132–137

    Google Scholar 

  • Swan DA, Bell B, Oakley CM et al (1971) Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Brit Heart J 33:671

    Article  PubMed  CAS  Google Scholar 

  • Ten Berg J, Suttorp M, Knaepen P et al (1994) Hypertrophie obstructive cardiomyopathy: initial results and long-term follow up after Morrow septal myectomy. Circulation 90:1781–1785

    Article  Google Scholar 

  • Thompson D, Naqvi N, Juul S (1980) Effects of propranolol on myocardial oxygen consumption, substrate extraction and hemodynamics in hypertrophie obstructive cardiomyopathy. Br Heart J 44:488–498

    Article  PubMed  CAS  Google Scholar 

  • Tiso N, Stephan D, Nava A et al (2001) Identifidation of mutations in the cardiac ryanodin receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194

    Article  PubMed  CAS  Google Scholar 

  • Towbin J, Bowles N (2002) The failing heart. Nature 415:227–233

    Article  PubMed  CAS  Google Scholar 

  • Tracy S, Hufnagel G, Chapman N (1992) Interesting problems in enteroviral inflammatory heart disease. Heart 17:79

    CAS  Google Scholar 

  • Tseng HC (1971) Interstitial myocarditis probably related to lithium carbonate intoxication. Arch Pathol 92

    Google Scholar 

  • Tzivoni D, Ratzrowski E, Biran S et al (1977) Complete heart block following therapeutic irradiation at the left side of the chest. Chest 71:231

    Article  PubMed  CAS  Google Scholar 

  • Watkins H, Rosenzweig A, Hwang D et al (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326:1108–1114

    Article  PubMed  CAS  Google Scholar 

  • Weiss RB, Grillo-Lopez AJ, Marsoni S et al (1986) Amsacrine associated cardiotoxicity: An analysis of 82 cases. J Chir One 105:67

    Google Scholar 

  • Wigle ED (1995) Novel insights into the clinical manifestations and treatment of hypertrophie cardiomyopathy. Curr Opin Cardiol 10:299

    Article  PubMed  CAS  Google Scholar 

  • Wigle ED, Felderhof CH, Silver MD, Adelman AG (1973) Hypertrophie obstructive cardiomyopathy. In: Fowler ED (ed) Myocardial diseases, p 297. Grune&Stratton, New York

    Google Scholar 

  • Wigle ED, Sasson Z, Henderson MA et al (1985) Hypertrophie cardiomyopathy, the importance of the site and the extent of hypertrophy. A review. Prog cardiovasc Dis 28:1

    Article  PubMed  CAS  Google Scholar 

  • Windorfer A (1966) Die akute Virus-Myokarditis beim Kind. Münch med Wschr 108:2213

    PubMed  CAS  Google Scholar 

  • Yamaguchi H, Ischimura T, Nishiyama S et al (1979) Hypertrophie non obstructive cardiomyopathy with giant negative T-waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Amer J Cardiol 44:401

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Görnandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Zeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Herz-Zentrum Bad Krozingen, Südring 15, 79188, Bad Krozingen, Germany

    H. Roskamm , F.-J. Neumann , D. Kalusche  & H.-P. Bestehorn , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Görnandt, L., Zeh, W. (2004). Kardiomyopathien. In: Roskamm, H., Neumann, FJ., Kalusche, D., Bestehorn, HP. (eds) Herzkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18649-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18649-3_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62220-5

  • Online ISBN: 978-3-642-18649-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation